Anastomotic Leaks following Esophagectomy for Esophageal and Gastroesophageal Junction Cancer: The Key Is the Multidisciplinary Management
GE - Portuguese Journal of Gastroenterology · 2023 · 30 (1) · 38-48
DOI: 10.1159/000520562 ↗Kurz gefasst
Fachartikel in der Zeitschrift GE - Portuguese Journal of Gastroenterology, online erschienen am 14.12.2021. Verfasst von Raquel Ortigão und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Department, Portuguese Oncology Institute of Porto, Porto, Portugal. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Anastomotic leakage after esophagectomy is associated with high mortality and impaired quality of life.
Aim
The objective of this work was to determine the effectiveness of management of esophageal anastomotic leakage (EAL) after esophagectomy for esophageal and gastroesophageal junction (GEJ) cancer.
Methods
Patients submitted to esophagectomy for esophageal and GEJ cancer at a tertiary oncology hospital between 2014 and 2019 (n = 119) were retrospectively reviewed and EAL risk factors and its management outcomes determined.
Results
Older age and nodal disease were identified as independent risk factors for anastomotic leak (adjusted OR 1.06, 95% CI 1.00–1.13, and adjusted OR 4.89, 95% CI 1.09–21.8). Patients with EAL spent more days in the intensive care unit (ICU; median 14 vs. 4 days) and had higher 30-day mortality (15 vs. 2%) and higher in-hospital mortality (35 vs. 4%). The first treatment option was surgical in 13 patients, endoscopic in 10, and conservative in 3. No significant differences were noticeable between these patients, but sepsis and large leakages were tendentially managed by surgery. At follow-up, 3 patients in the surgery group (23%) and 9 in the endoscopic group (90%) were discharged under an oral diet (p = 0.001). The in-hospital mortality rate was 38% in the surgical group, 33% in the conservative group, and 10% in endoscopic group (p = 0.132). In patients with EAL, the presence of septic shock at leak diagnosis was the only predictor of mortality (p = 0.004). ICU length-of-stay was non-significantly lower in the endoscopic therapy group (median 4 days, vs. 16 days in the surgical group, p = 0.212).
Conclusion
Risk factors for EAL may help change pre-procedural optimization. The results of this study suggest including an endoscopic approach for EAL.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology Department, Portuguese Oncology Institute of Porto, Porto, Portugal.
- Intensive Care Unit, Portuguese Oncology Institute of Porto, Porto, Portugal.
- MEDCIDS, Faculty of Medicine, University of Porto, Porto, Portugal.
- Surgery Department, Portuguese Oncology Institute of Porto, Porto, Portugal.
Zitieren
APA
Ortigão, R., Pereira, B., Silva, R., Pimentel-Nunes, P., Bastos, P., Abreu de Sousa, J., Faria, F., Dinis-Ribeiro, M., & Libânio, D. (2023). Anastomotic Leaks following Esophagectomy for Esophageal and Gastroesophageal Junction Cancer: The Key Is the Multidisciplinary Management. GE - Portuguese Journal of Gastroenterology, 30(1), 38-48. https://doi.org/10.1159/000520562
Vancouver
Ortigão R, Pereira B, Silva R, Pimentel-Nunes P, Bastos P, Abreu de Sousa J, et al. Anastomotic Leaks following Esophagectomy for Esophageal and Gastroesophageal Junction Cancer: The Key Is the Multidisciplinary Management. GE - Portuguese Journal of Gastroenterology. 2023;30(1):38-48. doi:10.1159/000520562
BibTeX
@article{Ortigo2023,
author = {Ortigão, Raquel and Pereira, Brigitte and Silva, Rui and Pimentel-Nunes, Pedro and Bastos, Pedro and Abreu de Sousa, Joaquim and Faria, Filomena and Dinis-Ribeiro, Mário and Libânio, Diogo},
title = {Anastomotic Leaks following Esophagectomy for Esophageal and Gastroesophageal Junction Cancer: The Key Is the Multidisciplinary Management},
journal = {GE - Portuguese Journal of Gastroenterology},
year = {2023},
volume = {30},
number = {1},
pages = {38--48},
doi = {10.1159/000520562}
}
EUVIMED